NCT00811447View on ClinicalTrials.gov

Taxotere New Indication - Gastric Cancer Treatment Registration Trial

PHASE3CompletedINTERVENTIONAL

Enrollment

243

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

Stomach Neoplasms

Interventions

DRUG

5-fluorouracil

600 mg/m²/day intravenous

DRUG

Cisplatin

60 mg/m² or 75 mg/m² intravenous

DRUG

Docetaxel

60 mg/m² intravenous

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Shanghai

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00811447 - Taxotere New Indication - Gastric Cancer Treatment Registration Trial | Biotech Hunter | Biotech Hunter